Astera Labs, Inc. (NASDAQ:ALAB) Forecasted to Post Q1 2024 Earnings of ($0.16) Per Share

Astera Labs, Inc. (NASDAQ:ALAB) – Investment analysts at Northland Capmk issued their Q1 2024 earnings per share estimates for shares of Astera Labs in a research note issued on Thursday, April 18th. Northland Capmk analyst G. Richard expects that the company will post earnings of ($0.16) per share for the quarter. Northland Capmk also issued estimates for Astera Labs’ Q2 2024 earnings at ($0.18) EPS, Q3 2024 earnings at ($0.16) EPS, Q4 2024 earnings at ($0.10) EPS, FY2024 earnings at ($0.65) EPS, Q1 2025 earnings at ($0.13) EPS, Q2 2025 earnings at ($0.10) EPS, Q3 2025 earnings at ($0.10) EPS, Q4 2025 earnings at ($0.09) EPS and FY2025 earnings at ($0.41) EPS.

Several other analysts also recently issued reports on the company. Deutsche Bank Aktiengesellschaft assumed coverage on Astera Labs in a research note on Monday, April 15th. They set a “buy” rating and a $85.00 price target for the company. Morgan Stanley started coverage on shares of Astera Labs in a research note on Monday, April 15th. They issued an “overweight” rating and a $81.00 target price on the stock. Roth Mkm initiated coverage on shares of Astera Labs in a report on Monday, April 15th. They set a “buy” rating and a $85.00 price target for the company. Craig Hallum started coverage on Astera Labs in a research report on Monday, April 15th. They set a “buy” rating and a $90.00 price objective for the company. Finally, Jefferies Financial Group started coverage on Astera Labs in a report on Monday, April 15th. They set a “buy” rating and a $85.00 price target for the company. Eleven research analysts have rated the stock with a buy rating, According to MarketBeat.com, Astera Labs has an average rating of “Buy” and an average target price of $86.09.

Astera Labs Trading Down 9.1 %

ALAB stock opened at $64.49 on Monday. Astera Labs has a 12 month low of $50.61 and a 12 month high of $95.21.

Institutional Trading of Astera Labs

A hedge fund recently bought a new stake in Astera Labs stock. Allspring Global Investments Holdings LLC purchased a new stake in Astera Labs, Inc. (NASDAQ:ALAB) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 251,596 shares of the company’s stock, valued at approximately $18,666,000. Allspring Global Investments Holdings LLC owned 0.16% of Astera Labs at the end of the most recent reporting period.

Insider Activity at Astera Labs

In other Astera Labs news, Director Jack R. Lazar purchased 10,000 shares of the stock in a transaction dated Friday, March 22nd. The stock was bought at an average price of $36.00 per share, for a total transaction of $360,000.00. Following the transaction, the director now directly owns 165,000 shares in the company, valued at $5,940,000. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.